Cheng Ji, Gao Jinbo, Shuai Xiaoming, Wang Guobin, Tao Kaixiong
Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Oncotarget. 2016 Jun 28;7(26):39216-39230. doi: 10.18632/oncotarget.9581.
Bariatric surgery has emerged as a competitive strategy for obese patients. However, its comparative efficacy against non-surgical treatments remains ill-defined, especially among nonseverely obese crowds. Therefore, we implemented a systematic review and meta-analysis in order for an academic addition to current literatures.
Literatures were retrieved from databases of PubMed, Web of Science, EMBASE and Cochrane Library. Randomized trials comparing surgical with non-surgical therapies for obesity were included. A Revised Jadad's Scale and Risk of Bias Summary were employed for methodological assessment. Subgroups analysis, sensitivity analysis and publication bias assessment were respectively performed in order to find out the source of heterogeneity, detect the outcome stability and potential publication bias.
25 randomized trials were eligibly included, totally comprising of 1194 participants. Both groups displayed well comparability concerning baseline parameters (P > 0.05). The pooled results of primary endpoints (weight loss and diabetic remission) revealed a significant advantage among surgical patients rather than those receiving non-surgical treatments (P < 0.05). Furthermore, except for certain cardiovascular indicators, bariatric surgery was superior to conventional arms in terms of metabolic secondary parameters (P < 0.05). Additionally, the pooled outcomes were confirmed to be stable by sensitivity analysis. Although Egger's test (P < 0.01) and Begg's test (P<0.05) had reported the presence of publication bias among included studies, "Trim-and-Fill" method verified that the pooled outcomes remained stable.
Bariatric surgery is a better therapeutic option for weight loss, irrespective of follow-up duration, surgical techniques and obesity levels.
减肥手术已成为肥胖患者的一种有竞争力的治疗策略。然而,其与非手术治疗相比的疗效仍不明确,尤其是在非重度肥胖人群中。因此,我们进行了一项系统评价和荟萃分析,以便为当前文献增添学术内容。
从PubMed、科学网、EMBASE和Cochrane图书馆数据库中检索文献。纳入比较手术与非手术治疗肥胖的随机试验。采用修订的Jadad量表和偏倚风险总结进行方法学评估。分别进行亚组分析、敏感性分析和发表偏倚评估,以找出异质性来源、检测结果稳定性和潜在的发表偏倚。
纳入25项随机试验,共1194名参与者。两组在基线参数方面具有良好的可比性(P>0.05)。主要终点(体重减轻和糖尿病缓解)的汇总结果显示,手术患者比接受非手术治疗的患者具有显著优势(P<0.05)。此外,除某些心血管指标外,减肥手术在代谢次要参数方面优于传统治疗组(P<0.05)。此外,敏感性分析证实汇总结果是稳定的。尽管Egger检验(P<0.01)和Begg检验(P<0.05)报告纳入研究中存在发表偏倚,但“修剪填充”方法证实汇总结果仍然稳定。
无论随访时间、手术技术和肥胖程度如何,减肥手术都是减肥的更好治疗选择。